Evidence map›Paper›PMID 25297874›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting type 1 IFN expression.

Daniel G Calame, Stacey L Mueller-Ortiz, John E Morales, Rick A Wetsel

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Cell Death and Infection: Implications for Host and Microbe.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Protective role of host complement system inFrontiers in immunology · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Innate and Adaptive Immune Responses duringMicrobiology spectrum · 2019
    Article
  15. Article
  16. Review
  17. Type I IFN Does Not Promote Susceptibility to Foodborne Listeria monocytogenes.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniel G CalameThe Brown Foundation Institute of Molecular Medicine, Research Center for Immunology and Autoimmune Diseases, The University of Texas Health Science Center at Houston, Houston, TX 77030; M.D./Ph.D. Program, University of Texas Medical School at Houston/The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030; and.
Stacey L Mueller-OrtizThe Brown Foundation Institute of Molecular Medicine, Research Center for Immunology and Autoimmune Diseases, The University of Texas Health Science Center at Houston, Houston, TX 77030;
John E MoralesThe Brown Foundation Institute of Molecular Medicine, Research Center for Immunology and Autoimmune Diseases, The University of Texas Health Science Center at Houston, Houston, TX 77030;
Rick A WetselThe Brown Foundation Institute of Molecular Medicine, Research Center for Immunology and Autoimmune Diseases, The University of Texas Health Science Center at Houston, Houston, TX 77030; Department of Biochemistry and Molecular Biology, University of Texas Medical School at Houston, Houston, TX 77030 Rick.A.Wetsel@uth.tmc.edu.
Brown Foundation · USThe University of Texas Health Science Center at Houston · US

Funding

Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
MURINE COMPLEMENT C5 DEFICIENCY--MOLECULAR BASISR01AI025011 · NIAID · WASHINGTON UNIVERSITY · PI WETSEL, RICK A. · 1987 to 2017
$4.6M
Center for Clinical and Translational Sciences (CCTS)TL1TR000369 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$1.9M
NCATS NIH HHS TL1 TR000369NCATS NIH HHS UL1 TR000371NIAID NIH HHS R01 AI025011
6 · The paper itself

Abstract

Listeria monocytogenes is a major cause of mortality resulting from food poisoning in the United States. In mice, C5 has been genetically linked to host resistance to listeriosis. Despite this genetic association, it remains poorly understood how C5 and its activation products, C5a and C5b, confer host protection to this Gram-positive intracellular bacterium. In this article, we show in a systemic infection model that the major receptor for C5a, C5aR1, is required for a normal robust host immune response against L. monocytogenes. In comparison with wild-type mice, C5aR1(-/-) mice had reduced survival and increased bacterial burden in their livers and spleens. Infected C5aR1(-/-) mice exhibited a dramatic reduction in all major subsets of splenocytes, which was associated with elevated caspase-3 activity and increased TUNEL staining. Because type 1 IFN has been reported to impede the host response to L. monocytogenes through the promotion of splenocyte death, we examined the effect of C5aR1 on type 1 IFN expression in vivo. Indeed, serum levels of IFN-α and IFN-β were significantly elevated in L. monocytogenes-infected C5aR1(-/-) mice. Similarly, the expression of TRAIL, a type 1 IFN target gene and a proapoptotic factor, was elevated in NK cells isolated from infected C5aR1(-/-) mice. Treatment of C5aR1(-/-) mice with a type 1 IFNR blocking Ab resulted in near-complete rescue of L. monocytogenes-induced mortality. Thus, these findings reveal a critical role for C5aR1 in host defense against L. monocytogenes through the suppression of type 1 IFN expression.

Indexed as

AnaphylatoxinsAnimalsAntibodiesApoptosisBacterial LoadCaspase 3Complement C5aComplement C5bGene ExpressionInterferon-alphaInterferon-betaListeria monocytogenesListeriosisLiverLymphocytesMaleAnaphylatoxinsAntibodiesC5AR1 protein, humanCasp3 protein, mouseCaspase 3Complement C5aComplement C5bInterferon-alphaInterferon-betaReceptor, Anaphylatoxin C5aReceptors, InterferonTNF-Related Apoptosis-Inducing LigandTnfsf10 protein, mouse

Identifiers

PMID25297874
PMCPMC4295506
OpenAlexW1867625646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.